Breaking Business News | Breaking business news AM | Breaking Business News PM

The Wall Street Journal: FDA grants emergency-use status to Abbott’s $5 COVID-19 rapid antigen test

27 Aug 2020

The U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response COVID-19 antigen test that is roughly the size of a credit card.


Read the full article here.
This content was originally published by MarketWatch.com - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By MarketWatch.com - Top Stories

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.

Download